Metabolic Syndrome Clinical Trial
Official title:
Study of Metabolic Syndrome in Patients Undergoing Endovascular Aortic Repair (EVAR)
This prospective study aims to identify the prevalence of metabolic syndrome in patients undergoing EVAR and the implications of metabolic syndrome on the postoperative outcome, the major complications, the thromboembolic events and the perioperative mortality and morbidity of the patients undergoing vascular surgery.
Status | Not yet recruiting |
Enrollment | 220 |
Est. completion date | December 11, 2022 |
Est. primary completion date | December 11, 2021 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - elective EVAR Exclusion Criteria: - Patients incapable to give informed consent - Pregnancy - Cancer - Systematic Inflammatory disease - Use of steroids - Emergency surgery - Prior ICU admission |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Thessaly |
Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015 May 19;313(19):1973-4. doi: 10.1001/jama.2015.4260. — View Citation
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Associa — View Citation
Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet. 2005 Sep 24-30;366(9491):1059-62. — View Citation
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Fernando Costa. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Bloo — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Postoperative delirium (POD) | Prevalence of POD in patients undergoing EVAR | 30 days, 6 and 12 months | |
Primary | Mortality | Patients after EVAR who died in 30 days | 30 days | |
Primary | Mortality | Patients after EVAR who died in 6 months | 6 months | |
Primary | Mortality | Patients after EVAR who died in 12 months | 12 months | |
Secondary | Systematic inflammatory response | Patients after EVAR that develop Systematic inflammatory response | 30 days | |
Secondary | Systematic inflammatory response | Patients after EVAR that develop Systematic inflammatory response | 6 months | |
Secondary | Systematic inflammatory response | Patients after EVAR that develop Systematic inflammatory response | 12 months | |
Secondary | Postimplantation syndrome | Patients after EVAR that develop Postimplantation syndrome | 30 days | |
Secondary | Postimplantation syndrome | Patients after EVAR that develop Postimplantation syndrome | 6 months | |
Secondary | Postimplantation syndrome | Patients after EVAR that develop Postimplantation syndrome | 12 months | |
Secondary | Renal insufficiency | Patients after EVAR that develop Renal insufficiency | 30 days | |
Secondary | Renal insufficiency | Patients after EVAR that develop Renal insufficiency | 6 months | |
Secondary | Renal insufficiency | Patients after EVAR that develop Renal insufficiency | 12 months | |
Secondary | Cardiovascular events | Incidence of cardiovascular events in patients after EVAR | 30 days | |
Secondary | Cardiovascular events | Incidence of cardiovascular events in patients after EVAR | 6 months | |
Secondary | Cardiovascular events | Incidence of cardiovascular events in patients after EVAR | 12 months | |
Secondary | Thromboembolic events | Incidence of thromboembolic events in patients after EVAR | 30 days | |
Secondary | Thromboembolic events | Incidence of thromboembolic events in patients after EVAR | 6 months | |
Secondary | Thromboembolic events | Incidence of thromboembolic events in patients after EVAR | 12 months | |
Secondary | Complications of surgical procedure | Incidence of Complications of surgical procedure | 30 days | |
Secondary | Complications of surgical procedure | Incidence of Complications of surgical procedure | 6 months | |
Secondary | Complications of surgical procedure | Incidence of Complications of surgical procedure | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |